Sex Differences in the Relation between Comorbidities and Prognosis in Hospitalized Patients with COVID-19
Table 1
Basic characteristics and comorbidities frequency of hospitalized patients with positive real-time reverse-transcription polymerase chain reaction test results for COVID-19.
Characteristics
Total
Women
Men
value1
Number of participants
4,356 (36.3)
1,996 (45.8)
2,360 (54.2)
—
Age (mean, SD), y
58.4 (18.5)
58.6 (18.6)
58.0 (18.4)
0.284
Underlying comorbidities
DM
761 (17.5)
409 (20.5)
352 (14.9)
<0.0001
Hypertension
717 (16.5)
391 (19.6)
326 (13.8)
<0.0001
CHD
675 (15.5)
341 (17.1)
334 (14.2)
0.008
CRD
276 (6.3)
140 (7.0)
136 (5.8)
0.091
Cancer
116 (2.7)
54 (2.7)
62 (2.6)
0.873
CKD
157 (3.6)
66 (3.3)
91 (3.9)
0.332
Any NCD
1752 (40.2)
870 (43.6)
882 (37.4)
<0.0001
Clinical outcome
Death, n (%)
658 (15.1)
289 (14.5)
369 (15.6)
0.288
Recovered/discharge, n (%)
3698 (84.9)
1707 (85.5)
1991 (84.4)
0.288
1 value between men and women in positive RT-PCR. Values are numbers and percentages otherwise indicated. RT-PCR, real-time reverse-transcription polymerase chain reaction; SD, standard deviation; CHD, coronary heart disease; CKD, chronic kidney disease; DM, diabetes mellitus; CRD, chronic respiratory disease; NCD, noncommunicable disease.
